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Abstract

In this dissertation is proposed a methodology to identify patient’s recovery patterns
after cardiovascular surgery based on laboratory tests results. The main purpose is to
enhance the understanding of the manifestations of postsurgical complications in patients
who underwent cardiovascular surgery. The analysis of patients’ recovery process is
based on the relationship between plasma calcium, ionized calcium and platelet count
over time.
Laboratory results from the James A. Haley Veterans' Hospital databases, related to
patients admitted to the Surgical Intensive Care Unit (SICU) after cardiac surgery
(coronary artery bypass, aortic value replacement and mitral valve replacement), are
used. These databases contain information regarding commonly ordered tests such as
Complete Blood Count tests (CBC) and Basic Metabolic Panel (BMP) for a large group
of patients over time. Physicians usually order these tests as a component of screening,
routine evaluation, or serial assessment. These test results, contain a large amount of
information used by most physicians during the diagnosis process and patient monitoring.
This study creates time series of some components of the aforementioned tests to
analyze their behavior during the perioperative and postoperative period. Time series
based clusters are developed to determine the similarities among tests results from four
different types of patients: patients who had a satisfactory recovery process without any
manifestation of complications, patients who experienced complications but survived,
vii

patients who experienced complications and then died during their recovery and patients
who died during the perioperative period.

As a conclusion, the time series based

clustering techniques were able to identify whether a patient is likely to fully recover
from the surgery, but it does not have the power to detect effectively results
corresponding to a patient experiencing complications.
The development of this methodology provides statistical evidence of the differences
among different patterns on patient recovery. It is clear that patients experiencing
complications have a steeper drop of test results after surgery, and also a non-stable trend
towards normal levels. The appropriate use of the proposed methodology could help to
timely anticipate complications in patient condition, improve the comprehensiveness of
the assessment of patient condition based on laboratory test results and enhance the
utilization of laboratory results databases.
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Chapter 1: Introduction

One of the challenges faced by healthcare providers is to develop methodologies to
effectively monitor patient condition during the cycle of care. The development of these
methodologies is important, since their implementation could reduce patient mortality or
improve their quality of life.

This dissertation addresses the development of a

methodology to effectively identify common patterns observed in laboratory test results
over time of patients who underwent cardiovascular surgery. The focus of this study is
the analysis of laboratory test results during the post-surgical period.
1.1 Background
It is estimated that diagnostic laboratory and imaging procedures represent the
majority of healthcare costs in the U.S. The expenditures on imaging procedures doubled
from $6.4 billion to $12.0 billion from 2000 to 2005 for just for Medicare’s users [1].
Nevertheless, the amount of information that is currently extracted from laboratory test
results is limited, due to the complexity of the interactions among them and the lack of
effective methods to assist physicians interpreting them.
Still, laboratory tests are one of the primary sources of information to diagnose and
monitor the patient’s condition. Commonly physicians make inferences about patient
condition based on the most recent test result, ignoring important factors such as the
patient’s tests history, relationships among different test results and their rate of change.
Overall, physicians are not trained to perform diagnostics considering sets of multiple
1

attributes that describe a patient’s condition. Yet, in many cases patients present complex
health scenarios. In the general practice of medicine physicians lack techniques and tools
that will help them detect temporal changes and hidden interactions among tests results.
For the most part, physicians depend on their experience and their ability to interpret a set
of laboratory results to best assess the patient’s current condition, and its possible future
state.
It is challenge for healthcare providers to improve the current utilization of tests
results and imaging procedures to timely identify possible complications in a patient’s
condition. This is even more relevant for patients suffering from chronic diseases (i.e.
heart disease) or patients with a compromised health condition such as those in intensive
care units (ICUs).
It is estimated, just in the US, that more than five million patients are admitted to
intensive care units yearly [2,3], being cardiovascular diseases and post-operatory
management two of the primary causes. These two patient populations represent a large
proportion of the deaths in the U.S.: 10% to 20% of the patients admitted in ICUs died in
hospitals across the US [2, 3] and 34.3% of the total deaths in the US are caused by
cardiovascular diseases [4].
1.1.1 Challenges in Interpreting Laboratory Test Results
There is a clear need to update current medical practices of monitoring patients to
improve outcomes. Identification of postsurgical complications will help physicians to
assess the likelihood of adverse outcomes, and then decide what interventions could
improve the condition of the patient.
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Unfortunately, physicians do not have means that allow them to do prospective
assessment of the evolution of the patient. Based on their experience and results from
different tests, physicians try to assess possible future events that could happen if nointerventions are done. Also, physicians are given a large set of indicators of patient
condition (i.e. imaging results, laboratory work, clinical history, etc.) and it is difficult to
fully extract all the information that is embedded to perform a comprehensive assessment
of patient condition. There are several tests and the hidden relations among them are not
easily recognized by the naked eye. It is necessary to develop comprehensive approaches
that enhance the analysis and interpretation of laboratory test results to give healthcare
providers the ability to make proper assessment of a patient’s condition over time,
reducing the occurrence of adverse outcomes.
At the same time, researchers on the healthcare engineering arena have to be aware
that the use of complicated techniques to analyze this big spectrum of data could
complicate the proper interpretation of the outcomes by the physician. All the decision
support tools have to be designed with the objective of being interpretable for any
physician in order to make it easily transferable to any clinic and to improve medical
decision on healthcare settings.
All these issues open a broad research field where there are numerous opportunities
for researches across a variety of disciplines for help healthcare providers to improve
patient care. In the next section it is described research opportunities that the author
explored on this dissertation.

3

1.1.2 Research Opportunities
Currently, research in healthcare engineering has become one of the most important
areas to generate high societal impact due to the integration of several areas of knowledge
to the service of people health improvement. A variety of multidisciplinary research
endeavors have been developed lately associated to healthcare. Many of them have as
their aims the development medical devices, methodologies to improve disease diagnosis
processes, analysis of pandemic outbreaks, resource allocation and patient monitoring
techniques, among others.
A fundamental opportunity identified by the author is in improving the effectiveness
of current practices in interpreting laboratory test results, by the development of a
dynamic approach that improves medical practice in monitoring postsurgical patient
condition.
Patient monitoring procedures have been developed basically to follow up patient
evolution during their stay in hospitalization. As mentioned before, laboratory tests
become one of the more used tools to monitor the patient’s health. According to the
patient’s condition, physicians order different sets of laboratory tests, to either confirm a
hypothesis about the evolution of the patient or just as a part of a routine screening rule.
Two common tests order by physicians to perform a general screening of a patient’s
condition are: Complete Blood Count test (CBC) and Basic Metabolic Panel (BMP).
These tests are utilized to identify abnormalities in heart rhythm and brain function, as
well as common conditions such as anemia and infections [5].
Given that patients who underwent complicated surgery procedures and patients
admitted in intensive care units (ICUs) represent a large proportion of the deaths in the
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US [2, 3], it is critical to develop research endeavors in related to the analysis of
laboratory test results to improve the monitoring process of these patient populations.
Based on the indentified opportunities, the objectives that are perused on this research are
stated in the next section.
1.2 Research Objectives
The overall objectives are threefold: (1) to improve the quality of medical inference
based on the better interpretation of laboratory tests data, (2) to enhance the timely
identification of postsurgical complications of patients who underwent cardiovascular
surgery, and (3) to advance the provision of a more personalized patient care.
As a result, the author expected that practices of postsurgical patient monitoring can
be enhanced by the development of this multi-test-based approach to guide medical
inference. A positive impact may be achieved in improving patient outcomes, reduction
in patient monitoring cost, decrease of time interpreting tests results and more
effectiveness in timely identifying patient complications.
1.3 Brief Research Description
This research proposes a methodology to analyze laboratory test results of patients
who underwent cardiovascular surgery, to assess their risk of complications and death
during each phase of the recovery cycle. The population included on this study is
composed by patients admitted at surgical intensive care unit (SICU) after undergoing
coronary artery bypass, aortic value replacement and mitral valve replacement at the
James A. Haley Veterans' Hospital (JAHVA), Tampa, Florida. The VA system is largest
healthcare delivery network in the US and has a significant historical dataset of medical
records, probably the most comprehensive in the country. In addition, the JAHVA is the
5

busiest facility in the VA system due to the number of active soldiers that are referred to
JAHVA. This provides a tremendous opportunity to have significant national impact and
potential transformed the way laboratory results are analyzed when providing medical
care to patients.
The analysis considers the characterization of the behavior of commonly ordered
laboratory tests to monitor patient condition during the postsurgical period. Initially, the
author applied non-parametric statistics to determine differences on the behavior of these
results across patients who experiences complications and patient who did not. Also, a
time series of laboratory test results was constructed to first identify different laboratory
result patterns and then generate patient recovery profiles over time based on the
decomposition of the time series in segments that represent different stages on the
patient’s recovery cycle. Several mathematical and statistical techniques are used to
achieve this goal, including time series clustering, data mining, fuzzy logic, among
others.
1.4 Organization of the Dissertation
The remainder of this dissertation is organized as follows:


Chapter 2 contains relevant literature review. The chapter describes current practices
in interpreting laboratory test results, and the analysis of the importance of commonly
ordered test in monitoring patient condition. This section also shows a description of
techniques for the analysis of time series, clustering and fuzzy logic.



Chapter 3 describes the research problem, description of the proposed approach and
the identification of challenges in interpreting laboratory tests results as a dynamic
function.
6



Chapter 4 describes the dataset construction process as well as the design, evaluation,
and validation of the proposed methodology for the analysis of laboratory tests
results.



Chapter 5 describes the performance of the proposed methodology for the analysis of
laboratory test results. Also an analysis of considerations for practical use of the
methodology is presented as well as guidelines for the user.



Chapter 6 concludes the dissertation by describing the expected benefits after the
implementation of the proposed methodology. It also describes possible directions for
future work.

7

Chapter 2: Literature Review

Chapter 2 contains relevant literature review. The chapter describes current practices
in interpreting laboratory test results, and the analysis of the importance of commonly
ordered tests in monitoring a patient’s condition. This section also shows a description of
techniques for the analysis of time series, clustering and fuzzy logic.
To better understand the value of research in improving the methodologies to
interpret laboratory test results, it is necessary to identify which are current practices used
by physicians and the relevant work that supports it. The next sections describe relevant
work and techniques that are used to interpret laboratory test results and time series data
in healthcare and in other industries.
2.1 Analysis of Laboratory Test Results: Current Practice
Development of standards for the analysis of blood test indicators is based on the
records from laboratories’ patient population or by recruiting a group of reference
subjects classified as ―healthy‖. Reference ranges are commonly created based on results
from the healthy population of an institution, including the values that correspond to the
95% (µ ± 2 standard deviations) of the results. This guideline relies on the fact that
several reference ranges are proven to follow a normal distribution [6]. However, there is
not an agreement on the methodology to determine these standards, resulting in methoddependent standards, and as a consequence, reference values vary across clinical
laboratories [6] i.e., a survey of 525 clinical laboratories showed that the reference range
8

of total plasma calcium varies from 8.3 to 8.8 milligrams per deciliter as the lower limit,
and from 10.2 to 10.7 milligrams per deciliter for the upper limit [7].
Methodologies to develop reference ranges are sometimes difficult to deploy due to
the time needed to collect samples, cost and knowledge needed to validate the results [8].
There are two basic reference ranges: health-associated and decision based ranges [9].
Health associated ranges are based on subjects in good health condition while decision
based ranges are based on limits that characterize a specific medical condition or
determines an intervention.
Notice that, even for homogenous populations, the behavior of the human body
differs among individuals. Existing reference ranges are used to identify abnormalities in
the patients’ test results without really knowing what a normal result is for a specific
patient, even when historical data about laboratory results is available, presenting a
challenge to healthcare providers to improve personalized healthcare delivery practices.
Unfortunately, these techniques mostly rely on the fact that single data points can be
an indicator of a condition or as a decision guideline to order an intervention, ignoring
what is happening to the patient over his/her cycle of care. Same laboratory test results
can be an indicator of different stages on the progression of a specific disease: for
example, figure 2.1 shows plasma calcium results for two patients during their
postoperative recovery in ICUs.
Cases like this could be often observed in medical practice. It is important to include
in the analysis of laboratory test results a temporal component that really captures what is
happening over time. This will allow physicians to have a more complete patient profile
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since they can compare if the result is normal according to the stage on the patient cycle
of care, and not only according to the corresponding reference range.
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Figure 2.1 Plasma calcium results for two patients during their recovery in ICUs
2.2 Patient Monitoring Techniques
This section presents a review of relevant research associated to monitoring
techniques of patients with heart disease or patients who underwent cardiovascular
surgery.
Research efforts in monitoring patient condition of patients suffering heart disease
reveal that four major aspects have been typically addressed: (1) understand physician’s
decision making process, (2) determine effective measures to assess patient health
condition and (3) modeling and predicting patient outcomes (i.e. logistic regression
approach) [18, 19, 20, 21, 22, 23].
There is a body of work related to the analysis of the relationship of patient
demographics and the differences in patient health. However, one aspect that has been
not addresses commonly is the differences in physician’s decision making process that
causes differences in the prescribed medicines or the disease management decisions.
10

Aspects like physician’s education, culture or age could influence these differences.
Differences iin physician’s diagnosis have been studied for patients suffering coronary
heart disease (CDH) [10]. In this study, the authors designed a factorial experiment to
test how four indicators affected physicians’ decisions regarding the diagnosis of CHD.
256 physicians were included on the study in a randomized manner. As a result, the
authors found that patient’s gender is one of the aspects that biased physicians’ decisions.
However, factors such as social class and race did not have a significant influence.
Other studies describe different factors that causes that physicians make suboptimal
diagnostic and decisions about treatments [11]. The main conclusion of this study is that
many of the listed biases affect, in the medical practice, how they gather and use
evidence while performing diagnoses. This situation could cause deficiencies in
healthcare delivery such as patient mismanagement, incorrect diagnosis and adverse
outcomes. Arnold and Anderson [45] stated that it is normal that physicians, like any
other person, have biases in their reasoning and the best strategy to mitigate their effect
on the decision making process is to make them aware that biases are always present, so
they can avoid them. As evidence of the positive effect of educating physicians about
biases in medical decision making, Gruppen et al. [46] found that physicians of an
institution were informed about the tendency to overestimate the likelihood of good
outcomes rather than adverse outcomes.
A common bias found in the literature, documented by Bornstein [47],

is the

tendency of physicians to stick with a treatment even though the patient does not show
any improvement. Among the reasons that may be associated to this practice are: to the

11

time invested on the patient, the treatment has been used for years in medical practice,
and for similar patients the treatment has worked successfully.
As a consequence of biases during patient diagnosis and monitoring, the evidencebased-medicine approach has become an alternative to avoid falling on biased diagnosis
[48,49].

Evidence-based-medicine is an approach that combines experiences from

multidisciplinary teams and patients to perform better disease diagnosis and management
[50].

By using objective information from the experiences of all clinical personnel,

several sources of bias can be mitigated.

One of the most important is physicians’

intuition what makes them to use just some pieces of information to make inferences
about a patient condition.
This issue in medical practice makes the author believe that there are commonly used
―rules of thumb‖ that may be bias based on physicians’ believes. This can be observed in
current practices in interpreting laboratory test results. It is commonly assumed
relationships between blood test results such as albumin and ionized calcium [51],
ignoring their relationship with other indicators.
Several researches have also identified the need to determine effective measures to
assess patient health condition. This process is conducted to validate a hypothesis related
to the relationship of an indicator with the presence of a condition on a patient. On this
matter there are standard tests (i.e. glucose level and the presence of diabetes, or platelet
count and hemophilia) but rarely physicians assess patient condition by comprehensively
considering multiple tests as markers of a specific condition. For patients with comorbidities it is more complicated to perform an accurate assessment of what exactly an
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indicator is showing and, even more critical and difficult to identify, in which stage of the
disease is the patient [12, 13, 14, 15, 16, 17]
Analyzing laboratory test results, including their temporal variation, become a
difficult task for physician due to the fact that there is a lack of techniques and tools that
will help them detect changes and hidden interactions among tests results over time.
Most of the work on this area analyzed patient condition using univariate measures and
static data.
There is extensive literature discussing methodologies to improve patient monitoring
procedures, but without simultaneously consider relevant aspects such as the effect of
time, multivariate indicators of patient condition or laboratory tests history. In general,
modeling patient disease progression overtime and patient monitoring can be achieved by
using time series analysis. One of the most common techniques to monitor patient
condition is following patient’s heartbeat. Time series analysis has been utilized to
determine differences between the heartbeat of healthy patients and patients with severe
congestive heart failure [52], a young healthy patient population versus an elderly
population [53], patients suffering from coronary artery disease with healthy patients
[53], and for the characterization of patients suffering from epilepsy [54].
Time series has also used to study variations on laboratory test results, such as
creatine [55]. Time series has also used to monitor routine diagnostic test data from for
patients with severe influenza (AH1N1) to elaborate strategies for its control [55].
However there are not extensive studies for the analysis of laboratory tests to monitor
patient condition during their hospitalization time.
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Although laboratory tests are used for general screening purposes in medical practice,
the characterization their tendencies overtime are not clearly stated in the literature.
However, modeling disease progression has been studied for multiple sclerosis [27] and,
mostly for detection of influenza pandemic outbreaks [55, 56, 57]. Although there are
books and extensive literature review about methods to interpret temporal data and
biostatistics [28], there are not applications related to the use of laboratory test results to
monitor patient condition in ICUs.
There are other techniques, such as Markov models and functional analysis[31, 32],
used to modeling disease progression [30] and screening, such as aortic aneurysm [29],
severe crohn’s disease [58,59], hepatitis C [60], infectious diseases [61], breast cancer
[62], prostate cancer [63], among other applications.
The analysis of laboratory test results presents a challenge, due to their multivariate
nature (components of CBC and BMP) and the non-standardized sampling process.
Unfortunately, the test results data is not uniformly sampled due to the lack of a
standardized sampling procedure. The periodicity of the sampling is determined by the
physician, which complicates a direct comparison of the patients’ evolution.
In other areas of knowledge, authors have done the analysis of similar data using
multivariate approaches for a numerous applications with the objective of characterizing
patients into clusters [24, 25, 26].
2.3 Similarities among Patients’ Recovery Cycle
Several authors have applied clustering methods to find similarities among elements
of a population. General clustering methods are modified to be applicable to dynamic
environments (i.e. k-means, c-means, agglomerative hierarchical method) for diverse
14

purposes [33, 34, 35]. The variation on these methods from their original form is based
on the replacement of similarity measures for static data with an expression for dynamic
data [36].

Commonly used similarity measures are Euclidean distance [25, 33, 35],

Pearsons’ correlation coefficient [36] and Kullback-Lieber distance [35]. The objective is
to maximize the sum of similarity measures between elements within a cluster [36].
Hard-partition-based [24, 34], fuzzy [33, 35, 37] and wavelet-based algorithms [38],
among other techniques, are also used to create time series clusters. However, none of
these techniques has shown an optimal procedure to estimate the total number of clusters
[36]. It is necessary to develop an approach to efficiently capture underlying patterns of
medical data that could help physicians obtain valuable information about patients’ risk
of complications and improve the quality of healthcare delivery.
2.4 Commonly Ordered Laboratory Tests
Laboratory tests are ordered by doctors as one of the sources to diagnose patients'
diseases and as a component of health condition progression. The most common blood
tests are the CBC and the BMP.
2.4.1 Complete Blood Count (CBC)
This test is compounded by a set of indicators such as red blood count, white blood
count, hemoglobin, hematocrit, and platelet count. The first four indicators are the main
reason to order a CBC, since they provide information to perform a general screening of
patient condition.
On the other hand, platelet levels are commonly tested before surgery and during the
procedure to test the ability of the human body to heal wounds and traumas generated by
the surgery. Platelets are cell fragments circulating in the blood stream and involved in
15

the cellular mechanisms leading to the formation of blood clots. Dysfunction or low
levels of platelets predispose the body to bleed. On the other hand, high levels may
increase the risk of thrombosis. Treatment to control platelet count could vary among
patients regarding to the severity of the disorder. It is noticed that if the detected amount
of platelets is slightly higher (or lower) than the acceptable limits, the intervention would
be different if the gap between those two is huge. It is necessary to develop a model to
analyze these dynamics to prevent possible adverse events and improve patient care
delivery.
Currently, doctors compare the results of platelets with its reference range. The
reference range is an interval used by doctors to compare whether a test result is
considered normal or not. Reference ranges usually consider 95% of the expected results
of a healthy population within its bounds. Unfortunately, doctors just realize that the
platelet count is low, or high, after the test, without having a system that helps them to
identify these complications in advance. The development of techniques that allow
doctors to anticipate dangerous levels of platelets will help in preventing the occurrence
of adverse events.
2.4.2 Basic Metabolic Panel (BMP)
The analysis of the components of the BMP provides important information regarding
fluid balance in the human body, particularly electrolytes.

In general, measuring

electrolytes is useful in monitoring vital normal functions such as heart rhythm and
neuromuscular function [6 and 7]. Some of the known conditions related to fluid balance
are muscle weakness, kidney disease, and heart disease. Specifically, calcium level is the
related to bone, teeth healthiness, muscle function, nerve function and blood clotting.
16

Calcium is found in the human body in three forms, physically complexed in the
bones, ionized (free in the blood stream) and bound to proteins, mostly plasma albumin.
The level of calcium is known to be associated to the level of plasma albumin, a protein
that constitutes 60% of plasma proteins [8]. The level of plasma calcium is considered
normal if it falls within 8.5 - 10.5 mg/dl. Even when there is a disorder in the plasma
albumin, physicians have developed an estimate of the plasma calcium, called corrected
calcium [9]. This expression has been proven to be a rough estimate [10 and 11], but it is
still used in practice.
Although, there is a relationship between plasma calcium and plasma albumin,
changes in plasma calcium could also be influenced by the variation in ionized calcium.
The ionized calcium is the metabolically active form of calcium that is available in the
blood for interactions in the cells, but is not often measured in clinical use, largely by
tradition. Physicians order the arterial blood gas test, mostly to check conditions such as
oxygenation problems, acid-base disorders, and breathing difficulties [12]. Normal levels
of ionized calcium are between 1.1-1.4 mmol/L.

Ionized calcium is not altered by

changes in plasma albumin, and it is generally believed that, ionized calcium is quite
stable and not altered acutely, although this study will investigate whether that belief is in
fact correct.
Based on preliminary observations, both plasma calcium and ionized calcium seem to
manifest a noticeable and sustained decrease after cardiovascular surgery. This behavior
appears to be a component of the negative acute phase response, and it appears to occur
regularly in the patient cohort that underwent this type of surgery. Figure 2.2 shows the
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patients’ average plasma calcium and ionized calcium during the first three days after
surgery, being zero the day of surgery.
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Figure 2.2 Plasma calcium and ionized calcium patterns after surgery

It is noticeable that both indicators fall dramatically after surgery, to levels that would
usually be considered quite low, but without any clinical manifestations in the patients.
However, if plasma calcium turns out to be a good marker of patient recovery, its
behavior is expected to be different for patients who experienced complications. The
next chapter presents a description of the methods used in this research to analyze the
plasma calcium patters during the patients’ recovery cycle.
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Chapter 3: Description of the Proposed Approach to the Analysis of Postsurgical
Laboratory Tests Results

The population used in this study is composed by 305 patients admitted to the SICU
of the JAHVA after undergoing cardiovascular surgery.

The researchers used de-

identified data to conduct the study, following the requirements established by IRB,
JAHVA R&D and HIPAA for such a study. The dataset contained information about
patients’ clinical history including date of admission, surgery type, date of surgery, date
of discharge and a complete history of laboratory tests results. Accurate dates and times
were required in order to establish the time series basis of the data, but all identifying
information was excluded.

A description of the assumptions and methods used to

analyze the data are presented in the next sections.
3.1 Surgical Procedures (Interventions)
Patients who underwent cardiovascular surgery were identified using a database
search based on assigned ICD-9 codes (International Classification of Diseases) [13] (see
table 3.1).

The ICD-9 codes provide a classification for diseases, symptoms,

abnormalities and causes of a disease. This classification assigns each disease to a
unique category and code. The World Health Organization (WHO) published these
codes as a guideline to compare diseases and symptoms around the globe.
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Twenty four cardiovascular procedures were included in this study; they are listed on
table 3.1. All patients undergoing one of the identified procedures during the time period
January 2006 to April 2008 were included.

Table 3.1 ICD-9 codes of the cardiovascular procedures included in the study
ICD – 9
Codes
36.10
36.11
36.12
36.13
36.14
36.15
36.16
36.17
36.19
39.22
39.23
39.24
39.25
39.26
39.28
39.29
ICD - 9
Codes
35.02
35.12
35.23
35.24
ICD - 9
Codes
35.01
35.11
35.21
35.22

Bypass Procedures
Aortocoronary bypass for heart revascularization, not
otherwise specified
(Aorto)coronary bypass of one coronary artery
(Aorto)coronary bypass of two coronary arteries
(Aorto)coronary bypass of three coronary arteries
(Aorto)coronary bypass of four or more coronary arteries
Single internal mammary-coronary artery bypass
Double internal mammary-coronary artery bypass
Abdominal-coronary artery bypass
Other bypass anastomosis for heart revascularization
Aorta-subclavian-carotid bypass
Other intrathoracic vascular shunt or bypass
Aorta-renal bypass
Aorta-iliac-femoral bypass
Other intra-abdominal vascular shunt or bypass
Extracranial-intracranial (EC-IC) vascular bypass
Other (peripheral) vascular shunt or bypass
Mitral Valve Procedures
Closed heart valvotomy, mitral valve
Open heart valvuloplasty of mitral valve without replacement
Replacement of mitral valve with tissue graft
Other replacement of mitral valve
Aortic Valve Procedures
Closed heart valvotomy, aortic valve
Open heart valvuloplasty of aortic valve without replacement
Replacement of aortic valve with tissue graft
Other replacement of aortic valve
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Initially, the surgical procedures and their corresponding dates were identified.
Subsequently, the surgery dates were used as a common time reference for the analysis of
the postsurgical period for each patient. Finally the surgery date for all the patients was
defined as ―time reference zero‖, delineating the beginning of the post-surgical period.
3.2 Reference Ranges
The behavior of the laboratory test results differ among individuals, even for
homogeneous populations. To address this issue, physicians use reference ranges to
determine if a specific test result is considered normal [14 and 15].
Reference ranges are commonly created based on results from the healthy population
of an institution, including the values that correspond to 95% (mean ±2 standard
deviations) of the results. This guideline relies on the fact that several reference ranges
are proven to follow a normal distribution [15]. For the purpose of this study, existing
reference ranges for laboratory test results are used to identify abnormalities in the test
results.
There is not agreement on the appropriate methodology to determine these standards,
resulting in method-dependent standards, and as a consequence, reference values vary
across clinical laboratories [16] i.e. a survey of 525 clinical laboratories showed that the
reference range of total plasma calcium varies from 8.3 to 8.8 milligrams per deciliter as
the lower bound, and from 10.2 to 10.7 milligrams per deciliter for the upper bound [17].
The authors developed reference ranges for the actual population used in this study
using historical plasma calcium data (preoperative). The most recent preoperative value
is used as a baseline to reference the postoperative values.
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3.3 Patient Population
The American College of Surgeons National Surgical Quality Improvement Program
(ACS NSQIP) is ―the first nationally validated, risk-adjusted, outcomes-based program
to measure and improve the quality of surgical care‖ [18]. Hospitals participating in the
program have access to different reports and support that help them make informed
decisions and provide better healthcare delivery. As a part of this program, the JAHVA
collects information about the evolution and outcomes of all patients undergoing
cardiovascular surgery.
Each patient record is reviewed and abstracted by a trained surgical advanced practice
nurse and the clinical information is integrated with quantitative data extracted from the
hospital database. This information will be used to identify which patients, within the
dataset, had postsurgical complications and which patients died after surgery. The
patients included in this study are classified in four groups according to their recovery
cycle and their outcome at the end of the cycle of care. The four patient types are listed
below:


Type 1. Patients who had a satisfactory recovery process and were discharged without
any identified complication.



Type 2. Patients who survived the perioperative period, had complications during the
recovery process, but survived and were discharged from the hospital.



Type 3. Patients who survived the perioperative period, had complications and then
died within 30 days after surgery.



Type 4. Patients who died during the initial postoperative period (within 4 days after
surgery)
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Excluded. Patients who died intraoperatively were excluded from the study as there
were no data available for analysis.

In the study patients who survived to day 30, but then died at a later date (typically
post-discharge), are not considered as deaths, since they are typically associated a new,
intercurrent event not present during the period of study. Examples of postsurgical
plasma calcium test results for these four groups of patients are shown in figures 3.1 a,
3.1 b, 3.1 c and 3.1 d:
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10.00

9.50

9.50

9.00

9.00
Plasma
Calcium
(mg/dl)

Plasma
Calcium
(mg/dl)

8.50
8.00

8.50
8.00
7.50

7.50

7.00
6.50

7.00
0
c. Type 3

10.00

1

2

3 4 5 6 7 8
Days after Surgery

0

9 10
d. Type 4

10.50
10.00

2

4
6
8 10 12
Days after Surgery

14

16

10.00
9.50

9.50

Plasma
Calcium
(mg/dl)

9.00

9.00

Plasma
Calcium
(mg/dl)

8.50
8.00

8.50
8.00

7.50
7.50

7.00

6.50

7.00
0

1

2

3 4 5 6 7 8
Days after Surgery

9 10

0

1
2
3
Days after Surgery

4

Figure 3.1 Examples of postsurgical plasma calcium for all patient types
According to surgeons at the JAHVA, patients who had a satisfactory recovery cycle
are expected to be sent home approximately within 7 days after surgery. As it can be
observed in figure 3.1 a, patients had a fall in plasma calcium, below the lower bound of
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the reference range, reaching its minimum approximately during the second day after
surgery. Then, the plasma calcium starts to go back to levels within the reference range
until it reaches levels near to the baseline. The time of recovery is longer for patients
who experienced complications. This is also reflected in the time required for plasma
calcium levels to return to normal levels. For these patients (figure 3.1 b) the continuous
decrease in the level of plasma calcium reflects the lack of stabilization on patient
condition. Type 3 patients (figure 3.1 c) had an initial increase in calcium level, but after
a few days the plasma calcium fell. On the other hand, patients who died during the initial
postoperative period show no recovery after the natural drop in plasma calcium.
In general the analysis of the patterns of laboratory tests results over time could
provide physicians with valuable information to assess patient recovery and anticipate
possible complications on patient condition. In the next section an approach to further
analyze laboratory test result patterns is presented.
3.4 Analysis and Characterization of Laboratory Test Results over Time
Several laboratory test results have a negative acute response to the surgery.
Physicians in the JAHVA have identified that other test results present an acute response
after surgery (e.g. platelet count).

For a normal patient, these indicators fall until

reaching a minimum, commonly below the lower bound of the reference range, and then
begin to recover normal levels.
In the case of plasma calcium, the minimum level is 7.734 mg / dl (mean value for
the population considered in this study), and then begins to recover its normal levels.
The time to return back to values within the reference range could vary among patients,
due to the differences in the recovery cycle. As a reference, the plasma calcium recovery
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cycle during the postsurgical period as well as some notations, are described as follows
(figure 3.2):
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Figure 3.2 Plasma calcium recovery cycle


Drop Phase (DP): the time-span immediately after surgery when the patient’s test
result level drops significantly until it shows a change in the decreasing trend. The
drop phase length is the time between surgery and the initial minimum (a).



Recovery Phase (RP): the time-span from the initial minimum (a), until the time
when the results reach normal levels. This phase can be further characterized: from
the initial minimum (a) until the test results reach the lower bound of the reference
range (b) and from the initial minimum (a) until return to the baseline (c).



RDP-min: Minimum result (R) at the end of the drop phase.



RG-min: Global minimum test result. For patients with a satisfactory recovery.
For example CaDP-min and ICaDP-min represent the minimum plasma calcium and

ionized calcium at the end of the drop phase. On the other hand, CaG-min and ICaG-min are
the global minimums.
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T-RG-min: Time after surgery corresponding to RG-min



T-RDP-min: Time after surgery corresponding to RDP-min. In many patients, presumably
uncomplicated, T-CaG-min and T-CaDP-min are expected to be the same.
Various characteristics of the patient’s recovery are analyzed. Since several of them

do not follow a normal distribution, non-parametric tests are performed to show the
relationship among these features and the patient’s recovery.
3.5 Identification of Postsurgical Complications Based on Test Results
Research focusing in data driven models to support medical decisions has increased
in the last years [39].

One of the aims of research in this field is to create enhanced

patient profiles that consider available medical information to improve the decision
making process. However, the complex nature of laboratory test results, may lead to
overlook patterns associated to patients who experienced postsurgical complications.
This may happen because some of these patterns are undetectable to the naked eye, and to
lack of robust techniques to conduct medical inference.

Thus it is important to

investigate if additional valuable information can be extracted from the CBC and BMP
components that will help to determine the likelihood of a patient suffering postsurgical
complications.
A CBC test is ordered to monitor disease progression, response to treatment or just as
a routine checkup [5]. A CBC test helps physicians to start investigating causes of
symptoms suffered by the patient, such as weakness, fatigue or pain [5].

Common

identifiable conditions based on a CBC test are anemia, infections and leukemia [6].
Atypical variations on the CBC results may lead to further investigate the underlying
medical condition that caused such symptoms. A CBC includes information about
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hemoglobin (Hbg), white cell count (WBC), white cell differential count, red blood count
(RBC), hematocrit (Hct), mean corpuscular volume (MCV), mean corpuscular
hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC), red cell
distribution width (RDW), platelet count, and mean platelet volume (MPV) [4]. When
ordering this test physicians are mostly interested in Hbg, WBC and RBC due to their
known relationship with most common diseases [5, 6, 40]. Thus physicians use the test is
to validate their hypothesis about the condition that the patient is suffering. Physicians
working with the research team strongly argue that the concurrent analysis of other
results could improve the assessment of the patient condition.
Similarly, BMP test is commonly ordered to assess patient condition. BMP measures
blood sugar levels, fluids balance, and kidney function [40], in terms of the levels of
sodium, potassium, creatinine, total bilirubin, total protein, carbon dioxide, glucose,
chloride, blood urea nitrogen (BUN) and calcium. Blood sugar levels are measured in
terms of glucose, which is the most important source of energy used by the human body.
Fluids balance is measured in terms of electrolytes (potassium, calcium and sodium),
needed to keep normal live functions, such as heart rhythm, muscle contraction, and brain
function [6]. Health conditions associated to electrolytes unbalance are heart disease,
muscle weakness, kidney disease, endocrine diseases, eating disorders, or bone disorders.
There are conditions that affect fluids balance, such as diarrhea, vomiting, fever, or
taking diuretics. Also, calcium levels are important for healthy bones and teeth, as well as
for normal muscle and nerve function.
It becomes necessary for physicians to enhance their ability to interpret laboratory test
results, to timely identify changes in a patient’s condition, order accurate interventions
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and make better patient care decisions. The fundamental goal is to improve the current
use of laboratory results by demonstrating how to extract valuable information from
existing clinical datasets.
Laboratory tests are ordered by physicians as part of a discrete monitoring process of
patient health evolution. As mentioned before, CBC and BMP are the most common tests
ordered by physicians to assess kidney functions, electrolytes and blood cells count. Ri
denotes a series of l laboratory results {k=1, . . . ,l}, for a given patient i {i=1, . . . , n}, for
a set of m tests {j=1, . . . ,m} can be represented as follows:

(3.1)

In real practice, laboratory tests are ordered by the physicians without following a
standard guideline about its periodicity. Moreover, there are no methodologies available
to determine an appropriate sampling rate for monitoring patients after undergoing
cardiovascular surgery. This creates a non-uniformly sampled process and a problem if a
physician wants to compare the recovery of two patients at the same time.
For a given patient i and test j, the vector Rij represents the history of laboratory test
results over time and

the kth result, sampled at time t {t=t1, . . . ,tk}.

(3.2)
Notice that the values of k denote the order in which the samples are taken. On the
other hand, t represents the actual time when the sample was taken. Since we want to
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analyze patients’ recovery cycle, time zero will be assumed as the time of surgery for
each patient.
For a non-uniformly sampled process, two patients may not have the same number of
samples, and they may not be taken at the same intervals. Moreover, depending on the
patient’s evolution, the length of stay will also vary among patients, increasing the
numbers of samples.

Non-uniformly sampled data creates a challenge for various

methods of analysis, such as time series, due to the need of converting these irregular
observations to periodic observations [36]. To construct standardized datasets, the
proponents will test the ability of several interpolation and modeling techniques to
capture the changes in the components of CBC and BMP over time. Once the best
technique is identified, the proponents will construct an equally time-spaced sequence of
test results for every patient.
Due to the trauma caused by the surgery, the loss of blood and the effort of the human
body to keep normal functions, a major disturbance is created in the patients’ test results
after surgery.

Two patterns are observed in test results immediately after surgery:

positive and negative acute response to the surgery. As the names suggest, a variable
shows a negative/positive acute response when its levels drop/increase significantly after
an event, in this case surgery. Physicians working with the research team have observed
that the calcium level falls until it reaches an average level of 7.5 mg / Dl (reference
range = [9, 10.5] mg/Dl), and then it begins to recover its normal levels after the second
day of the postsurgical period. The time to return back to the reference range could vary
among patients, due to the differences in the recovery cycle.
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3.6 Characterization of the Time Series
Based on the aforementioned classification, an analysis of the differences of the
patterns of the DP, RP, RDP-min, RG-min, T-RG-min, T-RDP-min for all patient types and
laboratory tests will be performed. This analysis will provide overall statistics about the
patient population. Parametric and non-parametric tests, as well as correlation analysis
were performed on the data to identify differences among patients’ laboratory test results
and patterns among patients who had postsurgical complications.
Current patient monitoring practices rely on the power of reference ranges in
detecting abnormalities in test results. Unfortunately, results are analyzed individually or
at most comparing two or three tests at the same time. Physicians do not have a proper
way of including more results (variables) to make inferences about the patient’s
condition. The proponents will identify the most relevant test results patterns associated
to patients experiencing complications. Also, interpretation of suspicious patterns in test
results will allow providers to improve current patient monitoring practices. The
development of multi-test-based monitoring process will assist physicians to observe and
understand interactions among test results and their relationship with patient’s health
evolution.
Healthcare information systems collect a great deal of data over time about patient
evolution. As stated before, this data needs to be analyzed to provide physicians with
useful information that enhance the diagnosis process. The understanding of the patient
evolution during the postsurgical period would help physicians to anticipate undesirable
changes in the patient’s condition and prescribe treatment(s) more effectively.

For

example, if two patients share the same result at some point in time, physicians cannot
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assure that the patients are in the same stage of their evolution after surgery. Certainly,
physicians use additional data to assess patient condition (symptoms described by the
patient, family history, demographics, etc.) but for patients with similar profile the
evolution may vary significantly.
Patient recovery patterns vary according to the patient’s health condition. Preliminary
observations show that patients experiencing complications spend more time recovering
normal levels (within the reference range) of platelets, calcium and mean platelet volume.
The construction of a patients’ similarity matrix, will provide a metric of the differences
among patients’ recovery.
Since all the tests results are in different scales, a time series of their rate of change
will be used to construct the patients’ similarity matrix.

Given two consecutive test

results rt-a and rt at time t-a and t, the rate of change at time t for a given test,

, can be

represented mathematically as follows:
(3.3)
(3.4)
Time series constructed based on the rate of change have different lengths due to the
non-uniformly sampled nature of monitoring process.

Commonly used similarity

measures, such as Euclidean distance, do not consider uneven time series. However, there
are methods such as dynamic time warping (DTW) that allows the calculation of
distances between time series with different length. DTW will be used to calculate
similarity among the patients’ recovery. Let Qi and Qi’ be the rate of change time series
of tests results of two different patients:

and

. The DTW algorithm will compare them by lining them up to
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minimize their difference. As a result, the algorithm will provide a k x k’ distance matrix,
Dij, where the Dij(t,t’) position represents the Euclidean distance between the tth and the
t’th element of the series Qi and Qi’ respectively for patient i and i’ , and test j. The
calculation of the Dij matrix elements will be performed for all the components of the
CBC and BMP for every patient.
The minimum distance between these time series is the sum of the elements of the
warping path W, where:
(3.5)
(3.6)
The warping path W, is the minimum path from the position Dij(1,1) to Dij (k,k’). The
minimum path will be determined using dynamic programming techniques.

The

mathematical expression that represents the minimum distance between these time series
is:
(3.7)
This calculation will be performed for each pair of rate of change time series, for each
pair of patients. As a result, m-matrices will be created for each patient, one for each
analyzed test.
The n x n matrix S, shows the patients’ similarity values, as follows:

(3.8)
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where

. This matrix summarizes the metrics used for comparison

between every two patients in the training set.
Several clustering techniques are tested to identify which one offers better
performance in clustering patients’ based on the matrix S. Also, the authors investigate
what is the best number of clusters that better describe patient’s evolution. The main
focus is fuzzy clustering techniques because they could provide more detailed
information about the patient condition, by providing membership values for a patient
into different clusters. Other techniques are also tested.
Fuzzy clustering techniques are used on this research to efficiently cluster patients
according to their similarities during the postsurgical period. It is expected that each one
of the clusters will represent a specific patient recovery pattern. Let

represent the

membership value of patient i in cluster v, where C is the total number of clusters. The
algorithm intends to minimize the expression:
(3.9)
Membership values should satisfy the following conditions:
and,

.

Next section shows an analysis of postsurgical plasma calcium, ionized calcium and
platelet count based on their characterization as time series, as well as their relation
during patients’ recovery phase.

33

Chapter 4: Analysis of Postsurgical Plasma Calcium, Ionized Calcium and Platelet
Count Test Results

This chapter presents an analysis of different features of postsurgical plasma calcium.
The main objectives are to characterize the behavior of postsurgical plasma calcium test
results and to find key differences on the plasma calcium results over time for the
different patient types.
4.1 Plasma Calcium: Reference Ranges
According to the USMLE [19] the reference range for plasma calcium is between 8.5
and 10.5 mg/dl. However, since the actual baseline data is available, reference ranges for
the population of this study are developed. The test results used to construct the reference
ranges are the last result before undergoing surgery. Figure 4.1 shows the frequency
distribution of the pre-surgical plasma calcium for the patient population included in the
study.

The reference range for the population of this study is [8.68 - 10.55] mg/dl

(μ=9.617; σ = 0.4675). The frequency distributions found in the literature do not differ
appreciably from the results obtained by constructing a reference range for plasma
calcium for the population of this study (reference ranges are constructed based on the
mean of the results from a healthy population ± 2 standard deviations).
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Although, the plasma calcium frequency distribution shows a fairly Gaussian shape,
the hypothesis of normality was rejected after performing a Kolmogorov-Smirnov test (pvalue=0.034); probably due to presence of some outliers that create a heavy tailed
frequency distribution. Yet a statistical test without the outliers yielded the same results
although with a more symmetrical distribution. Although small subgroups (types 3 and 4)
were not different by Wilcoxon test, we will assume that the parent distribution is not
normal and will employ non-parametric statistical methods where applicable.
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Figure 4.1 Frequency distribution of pre-surgical plasma calcium of the study population

To confirm that there were not baseline differences in the subsequently identified
patient groups, the four groups were compared by a Kruskal-Wallis test, which showed
no baseline difference. This was further analyzed by applying individual Wilcoxon tests
between pairs of groups as a ―post-hoc‖ test, and again there was no consistent difference
between baseline groups. A summary of the results is presented in table 4.1 and 4.2.
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Table 4.1 Mean and standard deviation of pre-surgical plasma calcium (mg/dl)

Mean
Standard Deviation

Population
9.617
0.467

Type 1
9.685
0.467

Type 2
9.550
0.462

Type 3
9.794
0.410

Type 4
9.520
0.427

Table 4.2 p-values from a two-sample Wilcoxon rank sum test for pre-surgical plasma calcium
Patient Type
Type 1 - Type 2
Type 1 - Type 3
Type 1 - Type 4
Type 2 - Type 3
Type 2 - Type 4
Type 3 - Type 4

P-Values
0.010
0.545
0.432
0.210
0.901
0.347

It is also noted that although the p-value obtained by comparing pre-surgical plasma
calcium for patient types 1 and 2 is equal to 0.01, the difference in the means is not
significant from the medical perspective, since these values are close to the central point
of the reference range.

In summary the pre-surgical plasma calcium results do not

provide enough information to assess how likely the patient is to have, or not,
postsurgical complications.
4.2 Plasma Calcium: Initial and Global Minimums
A decrease in plasma calcium levels was initially described in a study of patients with
pancreatitis; where it was found that low calcium is an indicator of a severe disease [20].
Also a decrease in plasma calcium has been reported in patients with sepsis [21]. In their
long medical and healthcare practice two of the committee members, Drs. Fabri and
Foulis, they have observed that a drop in the plasma calcium after cardiovascular surgery
is expected as a negative acute response to the surgery.
In this study, the plasma calcium drops below the lower bound of the reference range
for the majority of the patients reaching its minimum value CaDP-min, on average, during
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the second day after surgery. Once CaDP-min is reached, the plasma calcium begins to
return towards a normal level for patients who had a satisfactory recovery, while for
patients experiencing complications the plasma calcium does not show a stable increasing
trend.

For patients experiencing complications, the plasma calcium shows an initial

increase towards normal levels, and then it shows a non-stable trend. In some cases, these
variations make the plasma calcium results to drop even below the CaDP-min.
This global minimum, CaG-min, is expected to be the same as CaDP-min, for patient’s
type 1 and 4. For patients’ type 4, who died without experiencing any increase after the
initial minimum, the minimum plasma calcium is taken from the last test prior to death.
Table 4.3 presents a summary of the average values for CaDP-min and CaG-min.
Table 4.3 Mean and standard deviation for CaDP-min and CaG-min (mg/dl)

Ca DP-min
Ca G-min

Mean
Standard Deviation
Mean
Standard Deviation

Population
7.608
0.587
7.549
0.545

Type 1
7.646
0.598
7.608
0.557

Type 2
7.582
0.579
7.513
0.525

Type 3
7.540
0.416
7.100
0.424

Type 4
7.380
0.726
7.380
0.726

The values of CaG-min for patients type 3 and 4 are lower than for patients type 1 and
2. These values represent values reported prior to death for the majority of the patients,
and differ significantly from the CaDP-min. Figure 4.2 and 4.3 show the frequency
distribution of CaG-min and CaDP-min respectively.
Both frequency distributions show a Gaussian shape, but the normality assumption
was also rejected (pvalue=0.04). A two-sample Wilcoxon rank sum test was performed
to determine if there is a significant difference between the CaG-min and CaDP-min for all
patient types (table 4.4).
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Figure 4.2 Frequency distribution of CaG-min
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Figure 4.3 Frequency distribution of CaDP-min
The test results showed no significant difference in the values of minimum values of
CaG-min and CaDP-min. This implies that a single value of plasma calcium is not enough to
establish whether a patient is suffering complications or not. However, a single markedly
decreased level is suggestive of complications, which may signify that temporal analysis
of calcium levels could provide more information.
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Table 4.4 p-values from a two-sample Wilcoxon rank sum test of CaG-min and CaDP-min

Patient Type
Type 1 - Type 2
Type 1 - Type 3
Type 1 - Type 4
Type 2 - Type 3
Type 2 - Type 4
Type 3 - Type 4

p-values
Ca G-min
Ca DP-min

0.372
0.844
0.204
0.881
0.277
0.396

0.156
0.053
0.236
0.094
0.349
0.750

4.3 Plasma Calcium: T-CaG-min and T-CaDP-min
The time to reach the CaDP-min (T-CaDP-min), could be an important predictor of the
appearance of complications after surgery. Small values of T-CaDP-min can be caused by
the steepness on the drop of plasma calcium, whereas larger values could indicate a
smaller effect of the surgery on the level of plasma calcium for those patients. The TCaG-min should differ among patient’s groups due to the late appearance of complications
for patients’ type 2 and 3 during the recovery phase. It is expected that T-CaG-min for
these patients will be considerably larger than their T-CaDP-min. Table 4.5, figure 4.4 and
figure 4.5 and show the behavior of T-CaDP-min and T-CaG-min .
Table 4.5 Mean and standard deviation for T-CaDP-min and T-CaG-min

T-Ca DP-min
T-Ca G-min

Population
Mean
1.120
Standard Deviation
0.529
Mean
1.774
Standard Deviation
2.013
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Type 1
1.033
0.472
1.296
1.095

Type 2
1.215
0.574
2.122
2.353

Type 3
0.952
0.209
5.729
4.807

Type 4
0.880
0.396
0.880
0.396
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Figure 4.4 Frequency distribution of T-CaG-min
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Figure 4.5 Frequency distribution of T-CaDP-min
The mean values for T-CaDP-min show that the end of the drop phase occurs, on
average, at the beginning of the second day. The means among patient groups differ just
by a few hours, indicating that there is not a marked difference in the values of T-CaDPmin.

However, the values of T-CaG-min show a considerable difference among them. For

patients who experienced complications and died, the value of T-CaG-min is, on average,
5.729 days, while for patients who had a satisfactory recovery T-CaG-min is 1.296 days. A
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two-sample Wilcoxon rank sum test was performed to test the differences among the TCaDP-min for all patient types. The same analysis was carried out for T-CaG-min. Results
are summarized in table 4.6.
Table 4.6 p-values from a two-sample Wilcoxon rank sum test of T-CaG-min and T-CaDP-min

Patient Type
Type 1 - Type 2
Type 1 - Type 3
Type 1 - Type 4
Type 2 - Type 3
Type 2 - Type 4
Type 3 - Type 4

p-values
T-Ca G-min T-Ca DP-min

0.002
0.044
0.313
0.117
0.088
0.095

0.007
0.853
0.384
0.360
0.133
0.296

In general there is not a significant difference in the value of T-CaDP-min among
patients, indicating that all the patients experience the same drop in plasma calcium after
cardiovascular surgery. However, there is a significant difference in the values of T-CaGmin

among patients who experienced complications, type 2 and 3, and patients who did

not. Patients who experienced complications have larger variability than type 1 patients
during the recovery process.

For patients experiencing complications, the plasma

calcium drops even below the CaDP-min..
The analysis of the variation of plasma calcium provides valuable information to
assess patient condition.

Physicians can monitor the plasma calcium based on its

variation over time, having as reference the lowest level and the instance when it
occurred. A negative trend of plasma calcium should trigger an alarm, indicating that
there is a risk of dropping to levels close to the CaDP-min. The next section presents an
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analysis of the variation of plasma calcium over time. This analysis is based on plasma
calcium slopes during the drop and recovery phase.
4.4 Plasma Calcium Slopes during the Drop and Recovery Phase
The analysis of the variation of plasma calcium could help in the timely identification
of postsurgical complications.

It is necessary to analyze the temporal variation of

calcium to determine what information can be extracted.
The temporal variation of plasma calcium is analyzed in terms of the slope during the
drop and recovery phase.

Table 4.7 shows the mean and standard deviation of the

plasma calcium slopes during the drop and recovery phase for the population of this
study. A two-sample Wilcoxon rank sum test was performed to test the difference of the
plasma calcium slope during the drop and recovery phase for all patient types.
Table 4.7 Plasma calcium slopes during the drop and recovery phase

Population
Type 1
Type 2
Type 3
Type 4

Mean
Std. Dev.
Mean
Std. Dev.
Mean
Std. Dev.
Mean
Std. Dev.
Mean
Std. Dev.

Slope Drop Phase Slope T-Ca DP-min - 7th Day
-2.288
0.178
1.340
0.195
-2.415
0.207
1.291
0.188
-2.144
0.158
1.389
0.196
-2.523
-0.033
0.783
0.182
-2.784
1.433
-

As it was shown in the previous section, the behavior of the plasma calcium (slope)
during the drop phase is the same for all patients. However, there is a significant
difference in the values of slope during the recovery phase (table 4.8). Notice that the

42

comparisons were made between type 1, 2 and 3, since type 4 patients died during the
drop phase.
Table 4.8 p-values from a two-sample Wilcoxon rank sum test of the plasma calcium
slope during the drop and recovery phase for all patient types

Patient Type Slope Drop Phase
Type 1 - Type 2
0.0577
Type 1 - Type 3
0.6789
Type 1 - Type 4
0.5452
Type 2 - Type 3
0.2825
Type 2 - Type 4
0.2482
Type 3 - Type 4
0.8345

p-values
Slope T-Ca DP-min - 7th Day
0.017
0.0105
0.044
-

The recovery pattern of plasma calcium, following the initial minimum, appears to be
a useful indicator for assessing patient recovery. Since there is not a marked difference
among patients during the drop phase, differences in patient condition start to be
recognized after the plasma calcium reaches the CaDP-min. Variations on the ascending
trend of plasma calcium during the recovery phase should be an indicator of an
unrecognized complication on patient condition. This is even more critical if the test
results are close to the lower bound of the reference range or to the CaDP-min.
However, it could be argued that variations in plasma calcium are due to the
variations on plasma albumin, as it is commonly assumed. The next section presents an
analysis of the relationship of the variations on plasma calcium and ionized calcium.
4.5 Analysis of Ionized Calcium Results
The main objective of analyzing postsurgical ionized calcium, and its relationship
with variations in plasma calcium, is to demonstrate that variations in plasma calcium are
not principally due to a change in plasma albumin, but rather a proportional decrease in
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ionized calcium. Since the ionized calcium is mostly sampled during the perioperative
period, the analysis that is presented in next sections is based on its variations during the
drop phase, which is when the major changes in plasma calcium occur
4.5.1 Ionized Calcium: Reference Ranges
On average, the pre-surgical ionized calcium is 1.169 mmol/L, which falls within the
reference range which is [1.1, 1.4] mmol/L [22]. An ionized calcium reference range for
the population of this study was developed based on the last result before undergoing
surgery. The developed reference range is [0.955, 1.382] mmol/L (μ = 1.169; σ = 0.107).
The upper bounds of the reference ranges found in the literature do not differ
significantly from the results obtained by constructing this reference range for ionized
calcium (mean + 2σ), but the lower bound is considered low for this population.
Approximately, 16% of the patients have levels of ionized calcium below the lower
bound of the reference range prior to surgery.

Figure 4.6 shows the frequency

distribution of the pre-surgical ionized calcium.
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Figure 4.6 Frequency distribution of pre-surgical ionized calcium of the study population
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The pre-surgical ionized calcium for all the patient types appears to be similar. Table
4.9 shows the mean and standard deviation of pre-surgical ionized calcium by patient
type. Since the assumption of normality was rejected (p-value =0.018), a Kruskal-Wallis
non-parametric ANOVA test was performed to test whether there is a difference among
pre-surgical ionized calcium. It was found that there is not enough evidence to reject the
null hypothesis, thus there is no difference in the pre-surgical ionized calcium results
among patients (p-value = 0.982; Adjusted for ties p-value = 0.852).
Table 4.9 Mean and standard deviation for pre-surgical ionized calcium (mmol/L)
Population
Mean
1.169
Standard Deviation
0.107

Type 1
1.171
0.106

Type 2
1.168
0.109

Type 3
1.098
0.097

Type 4
1.196
0.040

As it was found for plasma calcium, the pre-surgical ionized calcium results do not
correlate with the presence of postsurgical complications.
4.5.2 Analysis of Ionized Calcium’s Drop Phase
During the drop phase, patients experienced a drop in the ionized calcium. On
average, the ionized calcium drops until it reaches 0.936 mmol/L (σ = 0.089) and then
starts to return back to normal. This minimum is reached, for almost 95% of the patients,
within the first 24 hours after surgery (µ = 0.5463 days; σ = 0.2637 days). Commonly,
during cardiovascular surgery, patients receive free calcium intravenously, but not postoperatively.
When intravenous calcium gluconate is administered, the rise in ionized calcium is
small and of very short duration, with the ionized calcium quickly returning to the
previously depressed levels.
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Table 4.10 summarizes the values of T-ICDP-min and ICaDP-min for the patients included
in the study. These data suggest that the ionized calcium regulatory system may be
―reset‖ resulting in a decrease in both ionized and total calcium.
Table 4.10 Mean and standard deviation for ionized calcium T-ICaDP-min and ICaDP-min .

ICa DP-min
T DP-min

Mean
Standard Deviation
Mean
Standard Deviation

Population
0.941
0.089
0.574
0.237

Type 1
0.951
0.086
0.555
0.211

Type 2
0.937
0.089
0.588
0.255

Type 3
0.872
0.068
0.602
0.149

Type 4
0.866
0.136
0.695
0.429

On average, the value of ICaDP-min is considerably lower for patients who died after
surgery. A Kruskal-Wallis non-parametric ANOVA test was conducted to test if there is
a significant difference in the values of ICaDP-min among patient types. The resulting pvalue was 0.779 (adjusted for ties p-value = 0.295), therefore, the null hypothesis is
accepted and it can be claimed that there is no statistical difference in the values of ICaDPmin

among patient types.
The same procedure was carried out for ionized calcium’s T-ICaDP-min. As a result, it

was found that there is not a significant difference in the values of T-ICaDP-min (p-value =
0.990, adjusted for ties p-value = 0.395) among patient types. Although, there is not
sufficient statistically evidence to claim that there is a difference in the values of T-CaDPmin and

ICaDP-min for the patients included in the study, a slight difference is noticed in the

mean values of T-ICaDP-min and ICaDP-min. For T-ICaDP-min the values are higher for
patients experiencing complications, whereas for ICaDP-min occurs the opposite.
The ionized slope during the drop phase could be an indicator of the effect of the
surgery on the patients. Table 4.11 summarizes the ionized calcium slope during the drop
phase for all patient types.
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Table 4.11 Ionized calcium slope during the drop phase for all patient types

Mean
Standard Deviation

Population
-0.999
1.425

Type 1
-1.005
1.150

Type 2
-0.976
1.668

Type 3
-1.187
1.168

Type 4
-1.359
0.774

After performing a Kruskal-Wallis non-parametric ANOVA test on the data, it was
found that there is not a significant difference in the values of the slopes of ionized
calcium during the drop phase (p-value = 0.999; adjusted for ties p-value = 0.489) among
patient types. However, it can be noticed that the steepness on the drop of ionized
calcium for patients who died during the perioperative period is higher.
Although, there is not enough statistical evidence, there are some hints that can help
in assessing patient condition. High negative slopes can be the consequence of the direct
effect of the operation. Notice that the same conclusions were drawn for plasma calcium
during the drop phase.
4.5.3 Cross Correlation Analysis between Plasma and Ionized Calcium
It is observed that postsurgical plasma and ionized calcium show a similar behavior
over time. Both present a noticeable drop during the perioperative period and then start to
return back to normal. A cross correlation analysis is performed to test the relationship
between the time series of plasma and ionized calcium results. The time series created
for this purpose are based on 12 hour-intervals.

Figure 4.7, shows the frequency

distribution of correlation between postsurgical plasma and ionized calcium.
On average, the correlation between both time series is 0.41 across the patient
population without performing any shifting on the time series (lag = 0). This average is
highly influenced by the heavy tail to the left on the frequency distribution. In general, a
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large portion of the population (70%) shows a correlation greater than 40% between both
time series, indicating that both time series behave approximately the same during the
postsurgical period.
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Figure 4.7 Frequency of correlations between postsurgical plasma and ionized calcium
For 19% of the patients on the study there is a negative correlation between plasma
and ionized calcium. This may be due to the administration of medications containing
calcium.

It is expected that if this effect is blocked the correlation will increase

positively. Unfortunately, there are a series of factors, such as the effect of treatments,
diet, metabolism and comorbidities, that affect the behavior of postsurgical laboratory
test results. This reality makes difficult the identification of possible sources of variability
in laboratory tests since we do not have access to other possible contributing factors
4.6 Platelet Count: Reference Ranges
According to the USMLE [19] the reference range for platelet count is from 150,000
to 450,000 per milliliter. Just as it was calculated for plasma calcium, reference ranges
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for the population of this study are developed based on test results. Initially, the last result
before undergoing surgery was extracted from the dataset for each patient. Figure 4.8
shows the frequency distribution of the pre-surgical platelet count.
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Figure 4.8 Frequency distribution of pre-surgical platelet count of the studied population
The reference range for the population of this study is [99,270 – 359,362] platelets
per milliliter (μ = 229,320; σ=65,021). The frequency distributions found in the literature
differ appreciably from the results obtained by constructing this reference range for
platelet count (mean ± 2σ). Although, the platelet count frequency distribution shows a
fairly Gaussian shape, the hypothesis of normality was rejected after performing a
Kolmogorov-Smirnov test (where the test statistic was equal to 0.0658 and the
corresponding p-value was equal to 0.0607), due to presence of some outliers that create
a heavy tailed frequency distribution.
Even though the normality assumption was rejected, it is possible that, if the number
of samples increases, the data could be modeled as a normal. Still it is important to
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determine whether baseline differences among the different type of patients are
significant. Results from the four groups were compared using a Kruskal-Wallis test and
further analyzed by applying individual Wilcoxon tests between pairs of groups as a
―post-hoc‖ test, just as it was done for plasma calcium. A summary of the results is
presented in table 4.12 and 4.13.
Table 4.12 Mean and standard deviation for pre-surgical platelet count (mg/dl)
Population
Mean
229.32
Standard Deviation
65.02

Type 1
234.15
62.92

Type 2
226.89
66.66

Type 3
203.60
76.66

Type 4
191.20
60.21

Table 4.13 p-values from a two-sample Wilcoxon rank sum test for pre-surgical platelet count
Patient Type P-Values
Type 1 - Type 2
0.325
Type 1 - Type 3
0.458
Type 1 - Type 4
0.152
Type 2 - Type 3
0.629
Type 2 - Type 4
0.245
Type 3 - Type 4
0.676

The results from the two-sample Wilcoxon rank sum test showed that there are not
significant differences between the pre-surgical platelet count among patient types.
However, it is noticeable that the lowers p-values correspond to the comparison between
patient groups 1 and 4, and 2 and 4, which are the most dissimilar types of patients, since
patients type 1 and 2 survived and patient type 4 died during the perioperative period.
Also, the higher p-values are associated to the comparison between patient type 2 and 3,
and 3 and 4. In the first case, the relation may be caused by the fact that these 2 patient
populations had complications during the postsurgical period and in the second case
because they both died.
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As a conclusion, the pre-surgical platelet count does not provide enough statistical
confidence to associate it to the likelihood of postsurgical complications. However, an
expected difference is observed on the mean of the patient groups where the pre-surgical
platelet count is lower for patients who had complications or died.
4.7 Platelet Count: Initial and Global Minimums
A decrease in platelet is anticipated for patients who underwent cardiovascular
surgery due to their consumption during the wound healing. In this study, platelet count
levels drop below the lower bound of the reference range for the majority of the patients.
As it was defined for plasma calcium, PDP-min represents the platelet count level when the
initial minimum is reached. For plasma calcium this value is reached, in average, during
the second day after surgery, day where the CaDP-min occurs. This event shows that both
test results fall dramatically during the first day after surgery, reaching their minimum at
the second day, which becomes a critical day for the patient care. For patients with a
satisfactory recovery process, once the minimum is reached, the platelet count goes back
to values within the reference range.

Results from patients who experienced

complications do not show this behavior; for them, the platelet count drops again, to
levels even lower level than the initial. As it was assumed for plasma calcium, PG-min is
expected to be the same as PDP-min, for patient’s type 1 and 4. Table 4.14 presents a
summary of the average values for PDP-min and PG-min.
Table 4.14 Mean and standard deviation for PDP-min and PG-min for all patient types (mg/dl)

P DP-min
P G-min

Mean
Standard Deviation
Mean
Standard Deviation

Population
132.09
56.28
122.09
50.24

Type 1
134.07
55.57
125.50
47.55
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Type 2
130.17
50.94
119.27
47.12

Type 3
69.60
20.21
55.40
24.93

Type 4
135.20
56.89
124.20
61.28

The mean value of PG-min for patients’ type 3 is the lowest. These values are mostly
captured prior to the patient’s death. These results differ significantly from the other
patients’ types. It is noticeable that for patient type 1, 2 and 4, PG-min is about the same
even when their recovery process and outcome differ. Since patients type 4 died during
the perioperative period, it is possible that their platelet count levels did not have time to
show a large decrease, since the main consumption of platelets occurs during the
recovery phase (when the complications during the wound healing process appear most
frequently). . Figures 4.9 and 4.10 show the frequency distribution of PG-min and PDP-min
respectively.
Both frequency distributions show a skewed Gaussian shape, which results in the
normality assumption not holding in this case. To test whether there is a significant
difference between PG-min and PDP-min for all patient types, a two-sample Wilcoxon rank
sum test was performed. Results are shown in table 4.15.
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Figure 4.9 Frequency distribution of PG-min
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Figure 4.10 Frequency distribution of PDP-min
The test results showed no significant difference in the values of minimum values of
PG-min and PDP-min, for patient type 1, 2 and 4. This implies that for these patient types,
the PDP-min corresponds to their PG-min in the majority of the cases. Based on these results,
the platelet count level for patients’ type 2 is not expected to drop below their PDP-min
after the drop phase, if it drops below PDP-min it is a clear symptom of the severity of the
complication. PG-min and PDP-min results from patients’ type 3 are significantly different
from the results from other patient types.
Table 4.15 p-values from a two-sample Wilcoxon rank sum test of PG-min and PDP-min

Patient Type
Type 1 - Type 2
Type 1 - Type 3
Type 1 - Type 4
Type 2 - Type 3
Type 2 - Type 4
Type 3 - Type 4

p-values
P G-min
P DP-min

0.3191
0.0009
0.91
0.0018
0.9748
0.0758
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0.7589
0.0028
0.8422
0.004
0.8536
0.0758

A single value of platelet count does not provide enough information to establish
whether a patient is suffering complications or not, since there is not a significant
difference between the results of patient type 1 and 2. However, for patients’ type 3 it
can be noticeable lower values of PG-min and PDP-min that for others, a single markedly
decreased level after the drop phase it can be interpreted as a sign of possible
complications on the patient recovery. Also, this suggests that a temporal analysis of
platelet count should be performed to confirm the appearance of complications.
4.8 Platelet Count: T-PG-min and T-PDP-min
The time to reach the PDP-min (T-PDP-min), is an important indicator to consider since
small values represent a rapid drop of platelet count caused by internal bleeding. Also,
large values could indicate that patient platelet production is enough to successfully heal
the wounds after surgery, indicating a mild effect of the surgery on its levels. As it was
stated for plasma calcium, the T-PG-min should differ among patient’s groups due to the
late appearance of complications for patients’ type 2 and 3 during the recovery phase. It
is expected that T-PG-min for these patients will be considerably larger than their T-PDP-min.
Figure 4.11, 4.12 and table 4.16 show the behavior of T-PDP-min and T-PG-min for the
population of this study.
Table 4.16 Mean and standard deviation for T-PDP-min and T-PG-min

T-P DP-min

Mean
Standard Deviation

Population
2.162
1.295

Type 1
2.113
1.154

Type 2
2.198
1.367

Type 3
3.177
1.563

Type 4
0.942
0.803

T-P G-min

Mean
Standard Deviation

4.205
5.790

3.823
4.958

4.406
6.346

4.119
1.673

1.029
0.350
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Figure 4.11 Frequency distribution of T-PG-min
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Figure 4.12 Frequency distribution of T-PDP-min
The mean value for T-PDP-min shows that the end of the drop phase occurs, on average,
at the beginning of the second day, just as it was found for plasma calcium. However, the
means among patient groups differ, in the case of patient type 1 and 2 just by a few hours,
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indicating that there is not a marked difference in the values of T-PDP-min for these patient
groups. On the other hand, for patients on group 3 the minimum occurred on average at
the beginning of the third day.
The values of T-PG-min show a considerable difference among patient groups. For
patients who experienced complications, the value of T-PG-min occurred at the fourth day
after surgery, while for patients’ type 1 at the third. A two-sample Wilcoxon rank sum
test was performed to test the differences among the values of T-PDP-min for all patient
types. The same analysis was carried out for T-PG-min. Results are summarized in table
4.17.
Table 4.17 p-values from a two-sample Wilcoxon rank sum test of T-PG-min and T-PDP-min
p-values

Patient Type
Type 1 - Type 2
Type 1 - Type 3
Type 1 - Type 4
Type 2 - Type 3
Type 2 - Type 4
Type 3 - Type 4

T-P G-min
0.5883
0.4013
0.6945
0.4323
0.8371
0.754

T-P DP-min
0.6388
0.1361
0.0282
0.1458
0.0419
0.0367

In general there is not a significant difference in the value of T-PG-min among patient
groups, indicating that all the patients experience a similar drop in platelet count after
cardiovascular surgery. This event also indicates that platelet count results are more
variable than plasma calcium overtime after the drop phase.

However, there is a

significant difference in the values of T-PDP-min among patients who died during the
perioperative period and the rest of them. This is an indicator that the platelet count
drops dramatically for these patients. This drop may be caused for complications during
the surgery associated with internal bleeding.
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The analysis of the variation of platelet count over time gives important information
to assess patient condition. Physicians can monitor the plasma calcium based on its
variation, having as reference the lowest level and the instance when it occurred. Just as it
was found for plasma calcium, a negative trend should trigger an alarm, indicating that
there is a risk of dropping to levels close to the PDP-min. As it was shown in table 4.15, the
decreasing trend in platelet count results should end by the third day if the recovery
process is satisfactory. The next section presents a deeper analysis of the variation of
platelet count over time, but focusing on tits slope during the drop and recovery phase.
4.9 Platelet Count Slopes during the Drop and Recovery Phases
The analysis of the variation of platelet count could help in the timely identification
of postsurgical complications associated with bleeding and coagulation problems. The
analysis will be based on the construction of a data set with the platelet count slopes
during the drop and recovery phase. Table 4.18 shows the mean and standard deviation
of the platelet count during the drop and recovery phase for the population of this study.
Table 4.18 Platelet count slopes during the drop and recovery phase for all patient types

Population
Type 1
Type 2
Type 3
Type 4

Mean
Std. Dev.
Mean
Std. Dev.
Mean
Std. Dev.
Mean
Std. Dev.
Mean
Std. Dev.

Slope Drop Phase Slope T-P DP-min - 7th Day
-16.728
0.037
29.620
0.078
-17.417
0.043
27.194
0.072
-13.559
0.036
20.394
0.085
-17.027
0.015
7.246
0.032
-71.689
113.193
-
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As shown in table 4.18, platelet count results have a negative slope for all patient
types during the drop phase. This behavior shows that there is a decrease in platelet count
for all patient types, but for patients’ type 4 it is steeper. As it was assumed before, this
behavior may be due to the presence of a massive loss of blood.
A two-sample Wilcoxon rank sum test was performed to test the difference of the
platelet count slope during the drop and recovery phase for all patient types. The results
from this analysis are shown in table 4.19.
Table 4.19 p-values from a two-sample Wilcoxon rank sum test of the plasma calcium
slope during the drop and recovery phase for all patient types

Patient Type
Type 1 - Type 2
Type 1 - Type 3
Type 1 - Type 4
Type 2 - Type 3
Type 2 - Type 4
Type 3 - Type 4

p-values
Slope Drop Phase Slope T DP-min - 7th Day
0.9611
0.4714
0.9391
0.5685
0.8887
0.8345

0.6543
0.2159
0.3366
-

The behavior of the platelet count (slope) during the drop phase is the same for all
patients, as it was confirmed for plasma calcium. However, although there is not a
significant difference in the values of slope during the recovery phase, it can be
noticeable that the p-values are lower when results from the comparison between patients
type 1 and 3, and 2 and 3; indicating that the slope for patients type 3 is steeper. Notice
that the comparisons were made between type 1, 2 and 3, since type 4 patients died
before this phase.
The recovery pattern of platelet count, following the initial minimum, appears to be a
useful indicator for assessing patient recovery. Since there is not a marked difference
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among patients during the drop phase, differences in patient condition start to be
recognized after the platelet count reaches the PDP-min. If the test results do not show the
expected ascending trend during the recovery phase, it can be assumed as an indicator of
an unrecognized complication on patient condition. This is even more critical if the test
results are close to the lower bound of the reference range or to the PDP-min. For almost
all the patients the value of PDP-min was below the lower bound of the reference range,
validating the usefulness of this benchmark.
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Chapter 5: Time Series Clustering of Laboratory Test Results

This chapter describes the performance of the proposed methodology for the analysis
of laboratory test results, as well as the description of the procedure for the construction
of the time series of laboratory test results and then, the patient clustering analyses as
well as considerations for practical use of the methodology are shown.
5.1 Construction of Datasets of Laboratory Test Results
Based on the results from the previous chapter, it is noticeable the direct relationship
between the results of plasma calcium and ionized calcium. Due to the high correlation
between plasma calcium and ionized calcium, ionized calcium is not included in the
multivariate clustering analysis. Consequently the multivariate clustering analysis is
based on plasma calcium and platelet count test results over time
For both tests, 8 different time series were constructed, based on data transformations
and data manipulation to avoid missing data. Since the data was not uniformly sampled,
it was not possible to perform a time series analysis with the data as is; it was necessary
to perform mathematical transformations on the data to have equally time-spaced
observation. To achieve this goal, three interpolation methods were applied on the data,
namely linear interpolation, polynomial interpolation and splines. Linear interpolation
provided the best fit in modeling the trends on the data set for both tests.

When

polynomial and splines were used, the estimation have more than n -1 degrees of
freedom, which resulted in curves that were not similar to the tendencies observed on the
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laboratory test results overtime. The use of linear interpolation allowed a more accurate
estimation of ―missing values‖. Based on the results after the implementation of linear
interpolation, the estimation of results was performed at equally-spaced points in time. A
detailed description of the methodology for the construction of these 8 time series is
presented below. For all datasets, the first value on this time series is the one associated
to the last result before surgery (baseline).


Linear Interpolation: The first data set was constructed using linear interpolation to
estimate the test results every 12 hours. The first value on this time series is the one
associated to the last result before surgery (baseline), and then the sequence of
estimations every 12 hours, based on the previous and the subsequent result in the
dataset at this points in time.



Linear Interpolation (12 Hours): This dataset differs from the previous. To construct
this dataset, a linear model was determined for to represent the behavior of the test
results in 12 hours intervals. Then, the model was used to estimate the results every
12 hours.



Linear Interpolation (24 Hours): This dataset differs from the previous one just in the
fact that the linear model was determined for to represent the behavior of the test
results in 24 hours intervals. Then, the model was used to estimate the results every
24 hours.



Rate of Change: Based on the results from the first dataset (Linear Interpolation), a
new dataset with the rate of change of results were constructed using equations 3.3
and 3.4.
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Rate of Change (12 Hours): Same as previous dataset but using as a reference the
Linear Interpolation (12 Hours) dataset.



Rate of Change (24 Hours): Same as previous dataset but using as a reference the
Linear Interpolation (24 Hours) dataset.



Time Intervals: Based on the experience of physicians in the committee, they stated
that it is expected that at the third day after surgery the patient should leave the ICU.
Then, at the sixth day it is expected that the patient is ready to perform routine tests to
authorize the discharge by the seventh day. If the patient stays longer than 7 days, this
may be an indicator of some complications or a slow recovery. Then it seemed
appropriate to construct a dataset estimating results every 3 days. So, this time series
starts with the baseline value, and then a linear model was determined for to represent
the behavior of the test results in 3 hours intervals, from 0 to the 3rd day after surgery,
from the 3rd day to the 6th, and from the 9th to the 12th.

Patients that stayed longer

than 12 days are considered as patients who experienced complications.


Segments: In the previous chapter, some features of laboratory test results were
identified. One of them is TDP-min , which will be used as a reference to create this
dataset. Once again, a linear model was created with the data points within the day of
surgery and the TDP-min. Then, a model between TDP-min and time where the results go
back within the reference range. Then the procedure is the same as it was shown for
the Time Intervals dataset.
Several time series clustering techniques were applied to all the constructed datasets

such as fuzzy logic based C-Means, Hierarchical and K-Means. Since for this setting it is
difficult to draw hard partition conclusions, regarding the potential risk of complications,
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fuzzy logic techniques are used to model the recovery process of patients after
cardiovascular surgery. The next section describes the results after the implementation of
the proposed methodology.
5.2 Multivariate Time Series Clustering
The implementation of multivariate time series clustering techniques provides a
representation of the potential risks that patients suffer during their stay in the SICUs. By
calculating these membership values, and then segmenting them by patient group, patient
risk profiles can be generated. If the constructed clusters allow the identification of
recovery patterns for the patient types defined before, then timely interventions can be
performed for patients that are expected to have complications.
Results from the implementation of multivariate clustering techniques are
summarized in tables 5.1, 5.2 and 5.3. Table 5.1 shows the membership values obtained
after the implementation of fuzzy logic clustering, table 5.2 fuzzy C-Means and 5.3 fuzzy
K-Means.
Fuzzy clustering does not yield ―perfectly‖ classify patients according to their
outcomes, maybe due to the similarities of the time series during the drop phase among
patient types. On the other hand linear interpolation classified all patients that suffered
complications in the same cluster. However, it classifies on the same cluster around half
of patients’ type 1 and 2, showing that this data set is not able to fully capture signs of
possible complications that might his death. The same situation is observed if the time
intervals and the segments based datasets are used. Also, around half of the patients who
survived after surgery are classified on the cluster 1, where almost all the patients who
died were classified.
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The dataset that appear to better capture the patients’ likelihood of having
complications is the rate of change.
Table 5.1 Time series fuzzy clustering results
Classification
Type 1 in Cluster 1
Type 2 in Cluster 1
Type 3 in Cluster 1
Type 4 in Cluster 1
Type 1 in Cluster 2
Type 2 in Cluster 2
Type 3 in Cluster 2
Type 4 in Cluster 2

Classification
Type 1 in Cluster 1
Type 2 in Cluster 1
Type 3 in Cluster 1
Type 4 in Cluster 1
Type 1 in Cluster 2
Type 2 in Cluster 2
Type 3 in Cluster 2
Type 4 in Cluster 2

Fuzzy Logic
(Linear Interpolation)
0.55
0.59
1.00
1.00
0.45
0.41
0.00
0.00

Fuzzy Logic
Fuzzy Logic
Fuzzy Logic
(Linear Interpolation 12 Hours) (Linear Interpolation 24 Hours) (Rate of Change)
0.45
0.54
0.27
0.56
0.56
0.29
1.00
1.00
0.60
0.75
1.00
1.00
0.55
0.46
0.73
0.44
0.44
0.71
0.00
0.00
0.40
0.25
0.00
0.00

Fuzzy Logic
(Rate of Change 12 Hours)
0.27
0.29
0.60
1.00
0.73
0.71
0.40
0.00

Fuzzy Logic
(Rate of Change 12 Hours)
0.27
0.29
0.60
1.00
0.73
0.71
0.40
0.00

Fuzzy Logic
(Segments)
0.48
0.51
1.00
0.75
0.52
0.49
0.00
0.25

Fuzzy Logic
(Time Intervals)
0.55
0.65
1.00
1.00
0.45
0.35
0.00
0.00

Table 5.2 Time series fuzzy C-Means clustering results
Classification
Type 1 in Cluster 1
Type 2 in Cluster 1
Type 3 in Cluster 1
Type 4 in Cluster 1
Type 1 in Cluster 2
Type 2 in Cluster 2
Type 3 in Cluster 2
Type 4 in Cluster 2

Classification
Type 1 in Cluster 1
Type 2 in Cluster 1
Type 3 in Cluster 1
Type 4 in Cluster 1
Type 1 in Cluster 2
Type 2 in Cluster 2
Type 3 in Cluster 2
Type 4 in Cluster 2

Fuzzy Logic C-Means
(Linear Interpolation)
0.36
0.34
0.00
0.25
0.64
0.66
1.00
0.75
Fuzzy Logic C-Means
(Rate of Change 12 Hours)
1.00
0.99
1.00
1.00
0.00
0.01
0.00
0.00

Fuzzy Logic C-Means
Fuzzy Logic C-Means
Fuzzy Logic C-Means
(Linear Interpoaltion 12 Hours) (Linear Interpoaltion 24 Hours) (Rate of Change)
0.70
0.61
1.00
0.71
0.69
0.99
1.00
1.00
1.00
0.75
0.75
1.00
0.30
0.39
0.00
0.29
0.31
0.01
0.00
0.00
0.00
0.25
0.25
0.00
Fuzzy Logic C-Means
(Rate of Change 12 Hours)
1.00
0.99
1.00
1.00
0.00
0.01
0.00
0.00
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Fuzzy Logic C-Means
(Segments)
0.66
0.68
1.00
0.75
0.34
0.32
0.00
0.25

Fuzzy Logic C-Means
(Time Intervals)
0.56
0.69
1.00
0.75
0.44
0.61
0.00
1.00

Table 5.3 Time series fuzzy K-Means clustering results
Classification
Type 1 in Cluster 1
Type 2 in Cluster 1
Type 3 in Cluster 1
Type 4 in Cluster 1
Type 1 in Cluster 2
Type 2 in Cluster 2
Type 3 in Cluster 2
Type 4 in Cluster 2

Classification
Type 1 in Cluster 1
Type 2 in Cluster 1
Type 3 in Cluster 1
Type 4 in Cluster 1
Type 1 in Cluster 2
Type 2 in Cluster 2
Type 3 in Cluster 2
Type 4 in Cluster 2

Fuzzy Logic K-Means
(Linear Interpolation)
0.27
0.21
0.00
0.00
0.73
0.79
1.00
1.00
Fuzzy Logic K-Means
(Rate of Change 12 Hours)
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00

Fuzzy Logic K-Means
Fuzzy Logic K-Means
Fuzzy Logic K-Means
(Linear Interpolation 12 Hours) (Linear Interpolation 24 Hours)
(Rate of Change)
0.22
0.28
0.00
0.14
0.23
0.01
0.00
0.00
0.00
0.25
0.25
0.00
0.78
0.72
1.00
0.86
0.77
0.99
1.00
1.00
1.00
0.75
0.75
1.00
Fuzzy Logic K-Means
(Rate of Change 12 Hours)
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00

Fuzzy Logic K-Means
(Segments)
0.77
0.80
1.00
0.75
0.23
0.20
0.00
0.25

Fuzzy Logic K-Means
(Time Intervals)
0.38
0.23
0.00
0.25
0.62
0.77
1.00
0.75

When it is used around of 70% of the patients who survive are classified on the same
group and just a 40% of the patients who died after complications where also classified
on that group. The results above show that when using fuzzy K-Means and fuzzy Cmeans the majority of the patients were mostly classified in the same cluster. This
classification maybe due to the fact that all patients’ groups presented a similar behavior
during the drop phase and during the recovery phase, thus the methods are unable to
determine differences on the time series. Most of the patients type 4 were classified
together due to their similarities in the steepness of their slope during the drop phase.
This classification was expected since the slopes during this phase appear to be steeper
than for the other patients in other groups.
The best performance of the methods is achieved when the rate of change every 12
hours is used to generate the clusters, since better membership values are obtained. All
the patients who survived the perioperative period are included in the cluster. Also when
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the clusters are created less overlapping is observed when fuzzy clustering techniques are
used.
Overall the three fuzzy methods utilized did not fully capture differences between
patient types 1 and 2. Patients type 1 and 2 presented very similar trends on their
laboratory tests results even after the drop phase. For most of these patients it is very
difficult to identify whether they have complications or not just by interpreting their
platelet count or plasma calcium. This is due to the different type of complications that
are reported during patients’ stay in the clinic. Many of the detected complications are
not directly related to the levels of plasma calcium or platelet count; it is possible that the
attending physicians identified them based on a different test, or based experience. Some
of the complications found on the patient population were reported as follows in the
information system: digestive system complication, pneumonia, arterial fibrillation,
systemic sepsis, urinary tract infection, pleural effusion, anemia, chest pain, stroke,
pulmonary insufficiency, acute renal failure, tachycardia, hypertension, reoperation for
bleeding, myocardial infarction, intubation, cardiac arrest, metabolic encephalopathy,
aortic valve disorder, acute lung edema, tracheotomy, asphyxia, and urine retention (more
than 50 different types of complications were listed on the database).
Because the nature of these complications lies with the reaction of the different
patients to the surgery, it is difficult to timely identify all of them with the information
provided by just two tests. However, since low platelet count, or a quick drop on it, are
related to complications such as internal bleeding, physicians could anticipate platelet
count related complications if its levels are regularly checked to confirm whether the
results are within the reference range and if the slope do not appear to be too steep. The
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same conclusion can be draw for plasma calcium due to? its relationship with the
mechanical function of the heart.

Therefore complications related with mechanical

failure such as strokes and chest pains can be anticipated by monitoring plasma calcium
levels.
Regarding the number of clusters, several tests have been performed to evaluate what
should be the appropriate number of clusters that should be included on the study. It
would be expected that, since the patients were classified in 4 categories, type 1, 2, 3 and
4, the best scenario is the one where all patients from the same type were classified in a
different cluster with membership values close to 1. If 4 clusters are constructed, all the
membership values tend to be equal to 0.25, which means that there is equal probability
to the patient to belong to each cluster. A similar situation occurred when 3 clusters are
designed, but in this case the membership values were close to 0.33. Figures 5.1 and 5.2
show the performance of the clustering techniques for one of the resulting datasets. It is
notice that when 2 clusters are used the overlapping is less.

Figure 5.1 Fuzzy Logic Clustering (linear interpolation 12 hours), K=2
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Figure 5.2 Fuzzy Logic Clustering (linear interpolation 12 hours), K=3

When K is increased, more fuzziness is introduced without increase the interpretation
power. Based on the experimentation, best results were obtained when the rate of change
is used instead of just the actual laboratory test result data. It is important to highlight
that even though one of the objectives in implementing fuzzy logic is to obtain some
fuzziness, if K increases over 2 the results will not provide us with useful information
about the behavior of the patients. The same results are obtained when other methods are
used.
Since the fuzziness is too high when more than 2 clusters are used, the best scenario
is when patients who did not die where classify in the same group and the remaining in
the other.

However, since there are similarities between patients who died after

complications and the ones who did not die after complications this goal may be partially
achievable.
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Further research efforts should include more tests in the analysis to find their key
features that help physicians in better detect suspicious patterns associated to
complications during patients’ recovery after cardiovascular surgery.
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Chapter 6: Conclusions and Future Work

The analysis of postsurgical plasma calcium provides valuable information to assist
physicians while conducting patient monitoring. Plasma calcium tests results should be
compared against the reference range to identify any signal that suggests a complication
on patient condition. However, every time a test result is analyzed it should to be
associated to the instance when the sample was taken. In this way the physician
determines to which period the test corresponds, decreasing (drop phase) or back to
normal levels (in the case of plasma calcium, around the 7th day after surgery).
It is expected that patients experience a consistent drop in plasma calcium and platelet
count during the perioperative period. The average length of this period on patients who
did not experienced complications is around 1 day for plasma calcium and 2 days for
platelet count, indicating that at the end of the second day after surgery both results
should show an increasing trend. If the test results continue dropping, it may indicate
complications on the patient’s condition.
The identification of different phases on patient recovery after cardiovascular surgery
(drop, recovery and stabilization phase) would help physicians to timely identify unsafe
patterns in plasma calcium and platelet count, associated to each of these phases. These
unsafe patters in both tests may be used as indicators of complications on the patient’s
condition. It was shown that all the patients behave fairly the same during the drop
phase, since their plasma calcium levels, platelet count, T-CaDP-min and T-PDP-min are
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statistically the same. However, the values of P DP-min and CaDP-min become a baseline to
assess patient recovery. It is important to mention that all the patients that reached an
initial minimum in their test results, and then had recurring drops during the recovery
phase, where reported as patients experiencing complications in the NSQIP records.
These complications were associated to different causes, so it is difficult to identify
whether the complication was mild or severe, or its effect on the patient’s outcome.
Several patients had more than one complication during their stay on the clinic. The
same patient could present episodes of tachycardia, sepsis, anemia or some other
complication at the same time or during his stay in the clinic. Yet what the records do not
show is the severity of the complication, and as a consequence, the real cause of the
complication that made the patient stay longer than the expected time in the clinic or die
is not identifiable.

Besides, the variety of the possible complications and their

interactions make even more difficult to really understand the relationship of variations
on test results and a specific complication.
It is also important to highlight that variations on laboratory test can be correlated
over time. After performing a cross correlation analysis of the time series of test results
of plasma calcium and ionized calcium, it was found a fairly high positive correlation
(0.4), between both (plasma albumin and ionized calcium) even though there are several
factors that affect the natural fall in both tests. For example the administration of free
calcium intravenously during surgery, creates a peak on the ionized calcium results’ time
series.
The complications reported by physicians during the patient’s stay in the clinic differ
among patients. This creates a problem if physicians want to will be able to timely
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identify them all, since not all of them can be easily detected by interpreting a single
blood test. In addition, many of the detected complications are not directly related to the
levels of a single test, instead they could be only be identified by the concurrent analysis
of several pieces of information from blood test results, radiographies, among other
screening procedures. However, the correct analysis of the appropriate indicator can be
very useful in identifying complications on patients’ condition.

In the case of the

population of study, the analysis of plasma calcium provides a good performance in
detecting possible complications on patient’s condition, if a transformation is performed
on the data (calculation of the rate of change every 12 hours).
It is necessary to perform a deeper analysis on the data to increase the level of
understanding of how to timely identify a complication on a patient. The data from the
NSQIP allow us to know the set of complications that a patient suffered during his
recovery, which could further help to segment the analyses by complication type to better
profile the trends of each test included on the CBC and BMP. Also, data from the
JAHVA includes information about patient’s demographics that could provide with
valuable information to construct a more comprehensive profile of the expected condition
of a patient of a specific race, age and gender at the moment of the detection of a specific
complication during the recovery process.
Since almost all patients included on this study that suffered complications had more
than one, it is likely that many of these complications triggered others. It is important to
understand the physiological process associated to the appearance of complication on a
patient to be able to anticipate it effectively. For example, a low level of white cells
could create the perfect situation for the appearance of infections of different kind that
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could end with the patient death. Thus, key tests should be identified since they are
markers of many of the most common complications, such as platelet count is clearly
associated to bleeding, and then find the data transformation that better helps to extract
valuable information from the data sets.
Future work will address the analysis of other laboratory tests that present a negative
acute response to the surgery to identify if the behavior of the tests studied on this
research is similar to the behavior of other test results. Also, the variations on plasma
calcium, and other laboratory tests, may be associated to patients’ characteristics such as
race, age and gender. Further studies could be focused on the analysis of the relationship
of these attributes and the recovery process of patients after undergoing cardiovascular
surgery.
The methodology presented on this work can be replicated to analyze laboratory tests
results associated to the monitoring process of patients after any surgical procedure. The
main challenge for the user is to determine the appropriate set of tests that should be
included on the analysis of patient postoperative condition.
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